688029 南微醫學
按盤價 
76.600 +9.300 (+13.819%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.499 | 14.215 | 10.719 | 11.694 | 10.250 |
| 總資產報酬率 ROA (%) | 7.049 | 11.728 | 8.786 | 9.641 | 8.720 |
| 投入資產回報率 ROIC (%) | 8.173 | 13.704 | 10.467 | 11.551 | 9.742 | 邊際利潤分析 |
| 銷售毛利率 (%) | 67.937 | 64.504 | 60.950 | 64.181 | 65.758 |
| 營業利潤率 (%) | 27.865 | 23.001 | 18.391 | 18.862 | 21.278 |
| 息稅前利潤/營業總收入 (%) | 26.198 | 20.198 | 15.514 | 20.454 | 23.863 |
| 淨利潤/營業總收入 (%) | 23.991 | 20.514 | 16.809 | 16.918 | 20.064 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.683 | 98.627 | 93.493 | 86.167 | 82.073 |
| 價值變動淨收益/利潤總額(%) | 2.909 | 4.928 | 11.752 | 17.328 | 16.357 |
| 營業外收支淨額/利潤總額(%) | 0.380 | 1.813 | 1.009 | 2.692 | 6.233 | 償債能力分析 |
| 流動比率 (X) | 5.521 | 5.067 | 5.343 | 4.665 | 5.933 |
| 速動比率 (X) | 4.623 | 4.264 | 4.327 | 4.010 | 5.421 |
| 資產負債率 (%) | 14.812 | 16.448 | 15.910 | 17.662 | 14.221 |
| 帶息債務/全部投入資本 (%) | 1.555 | 2.199 | 1.131 | 0.318 | -- |
| 股東權益/帶息債務 (%) | 6,202.437 | 4,358.737 | 8,580.466 | 30,894.838 | -205,378.912 |
| 股東權益/負債合計 (%) | 564.761 | 499.910 | 520.536 | 458.858 | 591.257 |
| 利息保障倍數 (X) | -14.776 | -6.258 | -5.064 | 19.103 | 20.374 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 54.595 | 51.670 | 57.921 | 51.787 | 0.000 |
| 存貨周轉天數 (天) | 218.997 | 228.962 | 223.846 | 157.347 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
